The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 2 , Pages 295-299 , August 2009

COUNTERPOINT: Pneumonectomy after chemoradiation: The risks of trimodality therapy

  • Mark J. Krasna, MD

      Affiliations

    • Corresponding Author InformationAddress for reprints: Mark J. Krasna, MD, The Cancer Institute, St Joseph Medical center, 7501 Osler Drive, Suite 104, Towson, MD 21204.

Received 7 June 2008 ,Revised 23 December 2008 ,Accepted 1 February 2009.

References 

  1. Boffa D, Allen M, Grab J, Gaissert H, Harpole D, Wright C. Data from the Society of Thoracic Surgeons General Thoracic database: the surgical management of primary lung tumors. J Thorac Cardiovasc Surg. 2008;135:247–254
  2. Beshay M, Carboni G, Hoksch B, Reymond MA, Schmid RA. The role of muscle flap in preventing bronchus stump insufficiency after pneumonectomy for malignant pleural mesothelioma in high-risk patients. Interact Cardiovasc Thorac Surg. 2008;7:621–625Epub 2008 Apr 1
  3. Pourel N, Santelmo N, Naafa N, Serre A, Hilgers W, Mineur L, et al. Concurrent cisplatin/etoposide plus 3D-conformal radiotherapy followed by surgery for stage IIIB (superior sulcus T3N0)/III non-small cell lung cancer yields a high rate of pathological complete response. Eur J Cardiothorac Surg. 2008;33:829–836
  4. Allen AM, Mentzer SJ, Yeap BY, Soto R, Baldini EH, Rabin MS, et al. Pneumonectomy after chemoradiation: the Dana-Farber Cancer Institute/Brigham and Women's Hospital experience. Cancer. 2008;112:1106–1113
  5. Barle'si F, Doddoli C, Chetaille B, Torre JP, Giudicelli R, Thomas P, et al. Survival and postoperative complication in daily practice after neoadjuvant therapy in resectable stage IIIA-N2 non-small cell lung cancer. Interact Cardiovasc Thorac Surg. 2003;2:558–562
  6. Uy KL, Darling G, Xu W, Yi QL, DePerrot M, Pierre AF, et al. Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancer. J Thorac Cardiovasc Surg. 2007;134:188–193
  7. Shaikh AY, Haraf DJ, Salama JK, Salgia R, Hoffman PC, Ferguson MK, et al. Chemotherapy and high dose radiotherapy followed by resection for locally advanced nonsmall cell lung cancers. Am J Clin Oncol. 2007;30:258–263
  8. Venuta F, Anile M, Diso D, Ibrahim M, DeGiacomo T, Rolla M, et al. Operative complications and early mortality after induction therapy for lung cancer. Eur J Cardiothorac Surg. 2007;31:714–718
  9. Edelman MJ, Sunthatalingam M, Burrows W, Kwong KF, Mitra N, Gamliel Z, et al. Phase I/II trial of hyperfractionated radiation and chemotherapy followed by surgery in stage III lung cancer. Ann Thorac Surg. 2008;86:903–910
  10. Albain K, Swann R, Rusch V, Turrisi A, Shepherd F, Smith J, et al., North AmericanLung Cancer Intergroup; Phase III study of concurrent chemotherapy and radiotherapy (CT/RT) vs CT/RT followed by surgical resection for stage IIIA(pN2) non-small cell lung cancer (NSCLC). Outcomes update of North American Intergroup 0139(RTOG 9309). Presented at 2005 ASCO Annual Meeting, Abstract #7104.
  11. Gamliel Z, Bardos J, Burrows WM, Sonett J, Suntharalingam M, Edelman MJ, et al. Pneumonectomyfor lung cancer can be performed safely following preoperative concurrent chemotherapy and high-dose radiation. Presented at the Society of Thoracic Surgeons, 42nd Annual Meeting, January 31, 2006, Chicago, Illinois.
  12. Radiation Therapy Oncology Group. RTOG 0229. A phase II trial of neoadjuvant therapy with concurrent chemotherapy and high dose radiotherapy followed by surgical resection and consdidative therapy for locally advanced non–small cell lung cancer. Available at: www.rtog.org/members/protocols/0229/0229.pdf. Accessed June 23, 2009.

PII: S0022-5223(09)00164-0

doi: 10.1016/j.jtcvs.2009.02.006

The Journal of Thoracic and Cardiovascular Surgery
Volume 138, Issue 2 , Pages 295-299 , August 2009

Article Tools